These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19120937)

  • 21. Laparoscopic staging and radiofrequency of hepatocellular carcinoma in liver ci rrhosis. A "bridge" treatment to liver transplantation.
    Casaccia M; Andorno E; Nardi I; Santori G; Troilo B; Barabino G; Di Domenico S; Panaro F; Valente U
    Hepatogastroenterology; 2009; 56(91-92):793-7. PubMed ID: 19621704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Care of the cirrhotic patient.
    Grewal P; Martin P
    Clin Liver Dis; 2009 May; 13(2):331-40. PubMed ID: 19442922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical staging of hepatocellular carcinoma.
    Meier V; Ramadori G
    Dig Dis; 2009; 27(2):131-41. PubMed ID: 19546551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection.
    Stock PG; Fung J
    Liver Transpl; 2009 Sep; 15(9):1003-6. PubMed ID: 19718639
    [No Abstract]   [Full Text] [Related]  

  • 25. The prognosis and survival analysis according to seven staging systems of hepatocellular carcinoma following curative resection.
    Choi SB; Lee JG; Kim KS; Yoon DS; Choi JS; Lee WJ; Kim BR
    Hepatogastroenterology; 2008; 55(88):2140-5. PubMed ID: 19260493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic role and correlation with staging systems of PIVKA-II compared with AFP.
    Baek YH; Lee JH; Jang JS; Lee SW; Han JY; Jeong JS; Choi JC; Kim HY; Han SY
    Hepatogastroenterology; 2009; 56(91-92):763-7. PubMed ID: 19621698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modern diagnosis and management of hepatocellular carcinoma.
    Marrero JA; Welling T
    Clin Liver Dis; 2009 May; 13(2):233-47. PubMed ID: 19442916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NASH and HCC.
    Page JM; Harrison SA
    Clin Liver Dis; 2009 Nov; 13(4):631-47. PubMed ID: 19818310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature].
    Neeff H; Makowiec F; Harder J; Gumpp V; Klock A; Thimme R; Drognitz O; Hopt UT
    Zentralbl Chir; 2009 Apr; 134(2):127-35. PubMed ID: 19382043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of hepatocellular carcinoma in the age of liver transplantation.
    Martin AP
    Int J Surg; 2009 Aug; 7(4):324-9. PubMed ID: 19643691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of BCLC treatment indications. Have BCLC modified our choice of treatment in HCC patients? A retrospective study.
    Maria S; Gaetano LG; Rosanna PT; Rosario L; Elisa M; Antonietta TM; Domenico R; Stefano P
    Hepatogastroenterology; 2009; 56(93):1090-4. PubMed ID: 19760948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Comparison of Staging Systems for Hepatocellular Carcinoma in a Multicenter US Cohort.
    Parikh ND; Scaglione S; Li Y; Powell C; Yerokun OA; Devlin P; Mumtaz S; Mittal S; Singal AG
    Clin Gastroenterol Hepatol; 2018 May; 16(5):781-782. PubMed ID: 28987503
    [No Abstract]   [Full Text] [Related]  

  • 33. Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables.
    Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Zanello M; Ravaioli M; Capussotti L; Pinna AD
    Arch Surg; 2009 Jan; 144(1):57-63; discussion 63. PubMed ID: 19153326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of MAGE-1, MAGE-3 and AFP mRNA as multimarker by real-time quantitative PCR assay: a possible predictor of hematogenous micrometastasis of hepatocellular carcinoma.
    Zhang Y; Li Q; Liu N; Song T; Liu Z; Guo R; Meng L
    Hepatogastroenterology; 2008; 55(88):2200-6. PubMed ID: 19260505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiating early and late recurrences after resection of HCC in cirrhotic patients: implications on surveillance, prevention, and treatment strategies.
    Poon RT
    Ann Surg Oncol; 2009 Apr; 16(4):792-4. PubMed ID: 19190964
    [No Abstract]   [Full Text] [Related]  

  • 36. Cyclo-oxygenase-2 overexpression is a feature of early and well-differentiated hepatocellular carcinoma with a favourable prognosis.
    Schmitz KJ; Wohlschlaeger J; Lang H; Sotiropoulos GC; Kaiser GM; Schmid KW; Baba HA
    J Clin Pathol; 2009 Aug; 62(8):690-3. PubMed ID: 19638539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
    Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
    Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognostic factors for survival in cirrhosis].
    Ennaifer R; Ouakaa-Kchaou A; BelHadj N; Elloumi H; Gargouri D; Kochlef A; Kilani A; Romani M; Kharrat J; Ghorbel A
    Tunis Med; 2007 Dec; 85(12):1039-43. PubMed ID: 19170384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The relation between hepatic venous pressure gradient and complications of liver cirrhosis].
    Paik YH
    Korean J Hepatol; 2008 Jun; 14(2):136-8. PubMed ID: 18617760
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.